Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Diabetes Mellitus, Insulin-Dependent, 12 × envafolimab × 90 days × Clear all

Sponsor

Conditions

Nasopharyngeal Carcinoma 1 Advanced Refractory Solid Tumors 1

Interventions

Nivolumab 3 Ipilimumab 2 tremelimumab 1 relatlimab 1 Opdualag 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡